Biography:
Dr. Moriarty is a professor of medicine at the University of Kansas Medical Center and the director of the medical center’s division of Clinical Pharmagology, Atherosclerosis Prevention Clinic and Lipid-apheresis Center in the department of Internal Medicine. Dr. Moriarty has completed over 75 clinical research studies as principal or co-investigator and authored over 100 scientific papers, serves as a key opinion leader in the field of lipidology, and as the past President of the International Society For Apheresis (ISFA) is one of the world’s foremost authorities on lipoprotein apheresis. Dr. Moriarty’s research program includes a variety of clinical trials focused on improving therapeutic options to treat and prevent atherosclerosis, blood rheology, and vascular disease.
Title : Treatment of Mild Cognitive Impairment Due to Alzheimerss Disease or Mild Dementia of Alzheimers Type: Design and Rationale of the Randomized Pivotal Study of RenewTM NCP 5